The enduring success of copyright’s flagship drug has undeniably shaped the drug landscape. However, putting money in companies heavily reliant on biosimilars and the waning patent exclusivity surrounding https://kobiutkr035866.shivawiki.com/8211995/the_blue_pill_and_drugmakers_a_risky_investment